Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

ViewRay, Inc. (VRAY)

4.63   -0.15 (-3.14%) 12-05 16:00
Open: 4.84 Pre. Close: 4.78
High: 4.84 Low: 4.55
Volume: 699,732 Market Cap: 840(M)

Technical analysis

as of: 2022-12-06 8:53:20 AM
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 5.71     One year: 6.67
Support: Support1: 4.46    Support2: 4.19
Resistance: Resistance1: 4.88    Resistance2: 5.71
Pivot: 4.65
Moving Average: MA(5): 4.73     MA(20): 4.6
MA(100): 3.81     MA(250): 3.76
MACD: MACD(12,26): 0.1     Signal(9): 0.1
Stochastic oscillator: %K(14,3): 73.2     %D(3): 80.8
RSI: RSI(14): 55.5
52-week: High: 5.86  Low: 2.39
Average Vol(K): 3-Month: 853 (K)  10-Days: 488 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ VRAY ] has closed above bottom band by 43.1%. Bollinger Bands are 35.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.85 - 4.88 4.88 - 4.9
Low: 4.48 - 4.52 4.52 - 4.55
Close: 4.58 - 4.64 4.64 - 4.68

Company Description

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.

Headline News

Mon, 05 Dec 2022
Project Architect - Raleigh, NC, US | Jobs - Archinect

Sun, 04 Dec 2022
TipRanks 'Perfect 10' List: 2 Stocks Under $5 That Are Worth Looking Into - TipRanks

Thu, 01 Dec 2022
Analysts have given ViewRay, Inc. (NASDAQ:VRAY) an average recommendation of "Moderate Buy." - Best Stocks

Tue, 29 Nov 2022
ViewRay, Inc. (NASDAQ:VRAY) Director Susan C. Schnabel Acquires 25000 Shares - MarketBeat

Tue, 29 Nov 2022
Tuesday 11/29 Insider Buying Report: VRAY, VOXX - Nasdaq

Wed, 23 Nov 2022
View Ray (VRAY) Investor Presentation - Slideshow (NASDAQ:VRAY) - Seeking Alpha

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 181 (M)
Shares Float 133 (M)
% Held by Insiders 2.8 (%)
% Held by Institutions 86.1 (%)
Shares Short 8,140 (K)
Shares Short P.Month 8,480 (K)

Stock Financials

EPS -0.65
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.57
Profit Margin (%) -121.3
Operating Margin (%) -123.5
Return on Assets (ttm) -26.1
Return on Equity (ttm) -96.1
Qtrly Rev. Growth 38
Gross Profit (p.s.) 0
Sales Per Share 0.48
EBITDA (p.s.) -0.57
Qtrly Earnings Growth 0
Operating Cash Flow -74 (M)
Levered Free Cash Flow -34 (M)

Stock Valuations

PE Ratio -7.19
PEG Ratio -0.9
Price to Book value 7.98
Price to Sales 9.55
Price to Cash Flow -11.29

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.